Skip to main content

Table 3 Data variables

From: The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants

Data variables for data collection form
Maternal Demographics DOB, race, highest education level
Lifestyle Tobacco and alcohol use, BMI
Current pregnancy history Final antepartum admission date, number of fetus(es), prenatal obstetrics visit, history of spontaneous preterm birth
Diagnoses (Yes/No) Insulin-dependent diabetes, maternal hypertension, preeclampsia, antepartum hemorrhage, placenta previa, abruptio placenta, fetal growth restriction, cervical insufficiency, preterm labor
Antibiotics administered within 30 days of delivery Diagnoses: positive urine cultures, genital tract infection, skin/soft tissue infection, vaginal yeast infection, PPROM, GBS, presumed or confirmed intraamniotic infection or chorioamnionitis; drug names, length of treatment
Other drugs Tocolytic therapy, betamethasone, antenatal corticosteroids; drug names, length of treatment
Infant baseline Delivery Date, time, gestational age, sex, birth weight (kg)
Randomization Date
Infant hospital course Outcomes at 1 week of age EOS diagnosis
1. If Yes: causative organism, antibiotics and dates of treatment
Days of antibiotics received during week 1 of life
Weekly Weight (kg), length (cm), LOS diagnosis (Yes/No), NEC diagnosis (Yes/No), death (Yes/No)
Nutrition (days 3, 7, 14, 28, 60) Enteral nutrition, type of milk or formula received, date subject reached full enteral feedings
Discharge Date of discharge, culture results, diagnoses: Grade 3 or 4 IVH, ROP, CLD, days of endotracheal intubation, positive blood cultures, positive respiratory cultures, positive urine cultures, positive cerebrospinal fluid cultures
Antibiotics prescribed Diagnosis, drug name, total number of days administered
IV antifungal medications Total number of days prescribed